We have heard much about how COVID-19 has created a paradigm shift in the use of telemedicine. A paper by Patel et al. (2021) uses claims data between January 1, 2020, to June 16, 2020 to measure this trend quantitatively. They find that in a… Read More »The rise of telemedicine
Looks like more good news on the COVID-19 vaccine front. Dr. Fauci’s prediction that the Pfizer/BioNTech foreshadowed positive news for future vaccines appears to have come true. Stat News reports: The Moderna vaccine reduced the risk of Covid-19 infection by 94.5%. There were 95 cases… Read More »COVID-19 vaccine: More good news as Moderna releases results
Interesting findings from an NBER working paper by Cronin and Evans (2020): Higher-quality nursing homes, as measured by inspection ratings, have substantially lower COVID-19 mortality. Quality does not predict the ability to prevent any COVID-19 resident or staff cases, but higher-quality establishments prevent the spread… Read More »COVID-19, nursing home quality and vaccination
Great news on progress for a COVID-19 vaccine from Pfizer. From their press release: Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis Analysis evaluated 94 confirmed… Read More »Positive news on a COVID-19 vaccine
That is the key question explored in a recent article from The Economist titled “Masked up, ready to battle bugs“. As individuals in developing nations leave crowded cities for fear of COVID, they may be at more risk for malaria due to the presence of… Read More »Will fighting COVID-19 disrupt progress against malaria?
Dasgupta et al. (2020) compares individual behavior in the COVID-19 pandemic with the 1665 London plague outbreak based on the descriptions by Daniel Defoe in A Journal of the Year of the Plague. The historical comparison is interesting throughout and merits a full read. Some… Read More »Pandemic comparison: COVID-19 vs. London Plague
COVID-19 is a global pandemic and finding a vaccine for COVID-19 would be a boon to societal. The value would be enormous. One study found that the value would be more than 1.1% of GDP. Since global GDP is $87.7 trillion, the value of a… Read More »What is the “reputational value” of developing a COVID vaccine?
The New York Times reports: California’s two largest public school districts said on Monday that instruction would be online-only in the fall, in the latest sign that school administrators are increasingly unwilling to risk crowding students back into classrooms until the coronavirus is fully under… Read More »LA: Distance learning only
Take a look at these two graphs. The first gives the number of new COVID-19 cases from John Hopkins University. It is a scary graph. https://coronavirus.jhu.edu/data/new-cases The second graph is the number of COVID deaths from IHME. Not nearly as bad. https://covid19.healthdata.org/united-states-of-america CDC reported death… Read More »What explains the decline in COVID deaths despite the rising number of cases?
Azar et al. (2020) use electronic health record data to examine differences in COVID-19 hospitalization rates by patient characteristics. The authors find that: …compared with non-Hispanic white patients, nonHispanic African American patients had 2.7 times the odds of hospitalization, after adjustment for age, sex, comorbidities,… Read More »Disparities in COVID-19 hospitalization rates